StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-13 | $0.63 | $0.63 | +0.16% | 0.3M |
| 05-14 | $0.62 | $0.62 | -0.66% | 0.3M |
| 05-15 | $0.62 | $0.59 | -4.94% | 0.3M |
| 05-18 | $0.59 | $0.59 | -0.59% | 0.3M |
| 05-19 | $0.60 | $0.62 | +3.33% | 0.4M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $116.67K | $116.67K | $33.26K | $65.00K |
Operating Income | $-6.59M | $-5.10M | $-3.53M | $-5.37M |
Net Income | $-6.50M | $-5.02M | $-1.45M | $-5.36M |
EPS (Diluted) | $-0.63 | $-0.51 | $-0.36 | $-0.89 |
Total Assets | $2.81M | $2.70M | $2.87M | $2.78M |
Total Liabilities | $672.02K | $758.70K | $681.08K | $184.35K |
Cash & Equivalents | $2.18M | $1.99M | $2.47M | $2.62M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 11.42M | 10.42M | 9.63M | 6.09M |
No sell-side coverage available for BFRG.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.